UNSPSC 42142523: Hypodermic needle

In this classification, this commodity indicates a product that is a hollow needle commonly used for rapid delivery or evacuation of liquids in a medical setting. US FDA regulates Hypodermic needle under 21 CFR 880. 557 and under FDA product code FMI. Most nations, for tariff and trade purposes, schedule these products under HS 901832.

UNSPSC 42142523 Hypodermic needle is a Commodity code, yet the recent state and local opportunities tagged under it do not reflect actual needle procurement. Instead, the code shows mixed and largely unrelated activity spanning irrigation control systems, occupational medical surveillance, duplex control panels, and intraosseous infusion devices—none of which align with hypodermic needle procurement. The one medical-equipment opportunity relevant to the code's nominal scope is Marion County, Florida's May 2026 solicitation for Vidacare EZ-IO intraosseous infusion systems (notice 09SS-103, due May 11, 2026), which addresses emergency infusion access but targets a specialized device rather than standard hypodermic needles. The Texas Health and Human Services Commission's July 2026 IFB for medical supplies and equipment at the Abilene State Supported Living Center (HHS0017603, due July 30, 2026) includes gastrostomy feeding tubes, catheters, and enteral feeding sets—related medical consumables but not hypodermic needles. The remaining solicitations—Georgia World Congress Center Authority's Calsense irrigation controller upgrades (RFP, due October 7, 2026), Washington State Department of Transportation's occupational medical surveillance services (RFP, due October 9, 2026), and various municipal irrigation and MRO supply procurements—bear no relationship to hypodermic needle procurement.

The code appears to suffer from systematic misclassification in recent state and local procurement activity. Geographic spread across the sample is broad, covering Georgia, Washington, Texas, and Florida, but this reflects the diversity of unrelated solicitations rather than concentrated needle-procurement activity. Business development professionals evaluating this code should not rely on the recent-opportunity block as representative of actual needle demand; instead, verify directly with state and local procurement offices—particularly healthcare systems, public health departments, and state medical supply contracts—to identify genuine hypodermic needle sourcing opportunities, which do not surface prominently in the tagged records reviewed here.